Episode Details
Back to Episodes
FDA Panel Votes on New COVID Vaccine
Published 1 week, 5 days ago
Description
The FDA’s advisory panel is set to vote this week on updating the COVID vaccine for the 2026-2027 season, targeting the dominant XFG (NB.1.8.1, or Stratus) variant — which spreads easily by evading immunity but doesn’t appear to cause more severe illness. Meanwhile, the FDA’s leadership has shifted, with Dr. Marty Makary stepping down and Kyle Diamantas now acting as commissioner.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/01e7b3c6823a6054